
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test
An experimental Organon drug for alleviating pain caused by endometriosis fell short of the main goal of a mid-stage clinical trial, leading the company to discontinue development of this product candidate, previously described as a key piece of its growth …